Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4632

1.

The Serotonin 5-HT1A Receptor Agonist Tandospirone Improves Executive Function in Common Marmosets.

Baba S, Murai T, Nakako T, Enomoto T, Ono M, Shimizu I, Ikeda K.

Behav Brain Res. 2015 Mar 21. pii: S0166-4328(15)00190-4. doi: 10.1016/j.bbr.2015.03.025. [Epub ahead of print]

PMID:
25804359
2.

Stages in the psychological resolution of schizophrenia.

Steggles GR.

Front Psychol. 2015 Mar 4;6:86. doi: 10.3389/fpsyg.2015.00086. eCollection 2015.

3.

Effects of modified electroconvulsive therapy on the cognitive function and blood parameters in female patients with schizophrenia.

Jiang Y, Zhang H, Wang Z, Zhao L, Lv L.

Int J Clin Exp Med. 2015 Jan 15;8(1):1349-55. eCollection 2015.

4.

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia.

Frydecka D, Misiak B, Pawlak-Adamska E, Karabon L, Tomkiewicz A, Sedlaczek P, Kiejna A, Beszłej JA.

Neuropsychiatr Dis Treat. 2015 Mar 5;11:575-84. doi: 10.2147/NDT.S74672. eCollection 2015.

5.

Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia.

Gawęda Ł, Krężołek M, Olbryś J, Turska A, Kokoszka A.

J Behav Ther Exp Psychiatry. 2015 Mar 5;48:98-104. doi: 10.1016/j.jbtep.2015.02.002. [Epub ahead of print]

PMID:
25775947
6.

The Role of Motivation in Cognitive Remediation for People with Schizophrenia.

Saperstein AM, Medalia A.

Curr Top Behav Neurosci. 2015 Mar 15. [Epub ahead of print]

PMID:
25772266
7.

Stimulation of the medial septum should benefit patients with temporal lobe epilepsy.

Fisher RS.

Med Hypotheses. 2015 Mar 2. pii: S0306-9877(15)00093-6. doi: 10.1016/j.mehy.2015.02.016. [Epub ahead of print]

PMID:
25771138
8.

Thinking Well: A randomised controlled feasibility study of a new CBT therapy targeting reasoning biases in people with distressing persecutory delusional beliefs.

Waller H, Emsley R, Freeman D, Bebbington P, Dunn G, Fowler D, Hardy A, Kuipers E, Garety P.

J Behav Ther Exp Psychiatry. 2015 Feb 24;48:82-89. doi: 10.1016/j.jbtep.2015.02.007. [Epub ahead of print]

PMID:
25770671
Free Article
9.

Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence.

Buonocore M, Bosia M, Riccaboni R, Bechi M, Spangaro M, Piantanida M, Cocchi F, Guglielmino C, Bianchi L, Smeraldi E, Cavallaro R.

Eur Psychiatry. 2015 Mar 7. pii: S0924-9338(15)00071-1. doi: 10.1016/j.eurpsy.2015.02.006. [Epub ahead of print]

PMID:
25758155
10.

Brief culturally adapted CBT for psychosis (CaCBTp): A randomized controlled trial from a low income country.

Naeem F, Saeed S, Irfan M, Kiran T, Mehmood N, Gul M, Munshi T, Ahmad S, Kazmi A, Husain N, Farooq S, Ayub M, Kingdon D.

Schizophr Res. 2015 Mar 7. pii: S0920-9964(15)00120-6. doi: 10.1016/j.schres.2015.02.015. [Epub ahead of print]

PMID:
25757714
11.

A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia.

Cellard C, Reeder C, Paradis-Giroux AA, Roy MA, Gilbert E, Ivers H, Bouchard RH, Maziade M, Wykes T.

Neuropsychol Rehabil. 2015 Mar 10:1-24. [Epub ahead of print]

PMID:
25753694
12.

From hospital admission to independent living: Is prediction possible?

Lipskaya-Velikovsky L, Kotler M, Easterbrook A, Jarus T.

Psychiatry Res. 2015 Apr 30;226(2-3):499-506. doi: 10.1016/j.psychres.2015.01.027. Epub 2015 Feb 24.

PMID:
25747682
13.

[Cognitive remediation therapy for children: Literature data and clinical application in a child and adolescent psychiatry department].

Doyen C, Contejean Y, Risler V, Asch M, Amado I, Launay C, Redon Pde B, Burnouf I, Kaye K.

Arch Pediatr. 2015 Apr;22(4):418-26. doi: 10.1016/j.arcped.2015.01.012. Epub 2015 Feb 28. French.

PMID:
25736104
14.

The evolution of cognitive-behavioral therapy for psychosis.

Mander H, Kingdon D.

Psychol Res Behav Manag. 2015 Feb 18;8:63-9. doi: 10.2147/PRBM.S52267. eCollection 2015. Review.

15.

Do ictal EEG characteristics predict treatment outcomes in schizophrenic patients undergoing electroconvulsive therapy?

Simsek GG, Zincir S, Gulec H, Eksioglu S, Semiz UB, Kurtulmus YS.

Nord J Psychiatry. 2015 Mar 3:1-6. [Epub ahead of print]

PMID:
25731192
16.

A Phase II study of a histamine H<sub>3</sub> receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy.

Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, Lieberman JA, Marder SR, Maruff P, McMahon RP, Seidman LJ, Peykamian MA.

Schizophr Res. 2015 Feb 24. pii: S0920-9964(15)00071-7. doi: 10.1016/j.schres.2015.01.041. [Epub ahead of print]

PMID:
25728831
17.

One-Year Randomized Controlled Trial and Follow-Up of Integrated Neurocognitive Therapy for Schizophrenia Outpatients.

Mueller DR, Schmidt SJ, Roder V.

Schizophr Bull. 2015 Feb 22. pii: sbu223. [Epub ahead of print]

PMID:
25713462
18.

We can manage depression better with technology.

Andrews G.

Aust Fam Physician. 2014 Dec;43(12):838-41.

PMID:
25705731
19.

Using Cognitive Behavioral Therapy on the Term Schizophrenia.

van der Pol A.

Schizophr Bull. 2015 Feb 9. pii: sbv008. [Epub ahead of print] No abstract available.

PMID:
25669851
20.

Is there a decline in cognitive functions after combined electroconvulsive therapy and antipsychotic therapy in treatment-refractory schizophrenia?

Pawełczyk A, Kołodziej-Kowalska E, Pawełczyk T, Rabe-Jabłońska J.

J Nerv Ment Dis. 2015 Mar;203(3):182-6. doi: 10.1097/NMD.0000000000000259.

PMID:
25668655
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk